Saturday, October 31, 2026

NASDAQ 100 Is 3% Up In The Last 5 Sessions

ViaNews Editorial Team

December 15, 2023

NASDAQ 100 Is 3% Up In The Last 5 Sessions

(VIANEWS) - NASDAQ 100 (NDX) has been up by 3.61% for the last 5 sessions. At 19:10 EST on Thursday, 14 December, NASDAQ 100 (NDX) is $16,600.55.

Volume

Today's last reported volume for NASDAQ 100 is 236535814, 90.59% below its average volume of 2514325755.82.

Concerning NASDAQ 100's yearly highs and lows, it's 55.56% up from its 52-week low and 0.36% down from its 52-week high.

Volatility

NASDAQ 100's last week, last month's, and last quarter's current intraday variation average was 0.83%, 0.23%, and 0.85%, respectively.

NASDAQ 100's highest amplitude of average volatility was 0.83% (last week), 0.51% (last month), and 0.85% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NASDAQ 100's is considered to be oversold (<=20).

News about

  • According to FXStreet on Tuesday, 12 December, "The S&P 500 futures, a risk barometer, is fluctuating between gains and losses while the US Dollar Index is consolidating recent gains near 104.00, as of writing."
  • According to FXStreet on Tuesday, 12 December, "The stock market's winning streak continues as the S&P 500 rose for the sixth straight week for the week ended Dec. 8. ", "The S&P 500 is now at its highest level all year and the highest since January 2022, the same month it hit an all-time high of 4,797. "
  • According to DailyForex on Tuesday, 12 December, "In the US, key indices like the Dow Jones, Nasdaq 100, and S&P 500 rose by about 0.50% while the dollar index jumped by 15 basis points."
  • According to DailyForex on Tuesday, 12 December, "In essence, the S&P 500 is poised on the precipice of significant developments, marked by the potential for a game-changing breakout. "
  • According to MarketWatch on Tuesday, 12 December, "The stock has gained 47% in the year to date, while the S&P 500 has gained 20%."

More news about NASDAQ 100 (NDX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com